col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

61 Results       Page 1

SAGE Publications: Journal of Pharmacy Practice
  original article Date Title Authors   All Authors
1 [GO] 2023―Dec―13 Comparison of Fixed Dosing vs Train of Four Titration of Cisatracurium in COVID-19 ARDS Patients Oyshik Banerjee, Jessica L. Elefritz, Bruce A. Doepker, Sara A. Atyia, Nathan E. Brummel, Rachel M. Smith, et al. (+2)
2 [GO] 2023―Nov―15 Impact of a Pharmacist-Managed Telemedicine Pharmacotherapy Clinic in the Era of COVID-19 Francheska Marte, Jessica Bianco, Amanda Martinez, Nicholas Carris
3 [GO] 2023―Aug―22 Systematic Review: Safety and Efficacy of mRNA COVID-19 Vaccines in Pregnant Women Julie Ngoc Lam, Jeffrey Nehira, Olivia Phung, Bin Deng
4 [GO] 2023―Aug―19 Evaluation of a Pharmacist-Led COVID-19 Vaccination Program in a Hospital Setting Laura L. John, Sydney Armbrust, Irina V. Haller, Colleen M. Renier, Alexa Brown, Elizabeth Monson
5 [GO] 2023―Mar―21 Pharmacy Intern Involvement in COVID-19 Immunization Practices in New York State Jane Shtaynberg, Suzanna Gim, Rebecca Cope, Katherine Maddox, Keith DelMonte, Courtney C. Tackes, Richard F. O’Brocta
6 [GO] 2023―Feb―20 Tocilizumab Versus Baricitinib for the Treatment of COVID-19 in Patients With Obesity Bradley S. Troyer, Nicole Kovacic Scherrer, Jeffrey Garavaglia
7 [GO] 2022―Dec―27 Pharmacists’ Perceptions of Mental Well-Being and Immunization Safety During COVID-19 Emily Peel, Chinelo C. Orji, Shelbie Ogan, Julie Gould, Gretta Leckbee, Carolyn M. Brown, Nathan Pope
8 [GO] 2022―Dec―20 A Case Report of Sudden Sensorineural Hearing Loss (SSNHL) After Administration of the COVID-19 Vaccine Justin Andrade, Lauren Sessa, Moshe Ephrat, James Truong, Robert DiGregorio
9 [GO] 2022―Oct―27 Controlling Blood Pressure During a Pandemic: The Impact of Telepharmacy for Primary Care Patients Bailey E. Bruns, Shirley A. Lorenzo-Castro, Genevieve M. Hale
10 [GO] 2022―Oct―15 Assessing Community Pharmacists’ Perception on Readiness to Initiate Point-of-Care Testing for SARS-CoV-2 in New York State During the Pandemic Ruth O. Ngwu, Ryan Lindeau, Laura M Bielecki, Christopher J. Daly
11 [GO] 2022―Oct―11 Transplant Pharmacists’ Experience With Telehealth During the COVID-19 Pandemic Karen Khalil, Demetra Tsapepas, Patricia West-Thielke
12 [GO] 2022―Oct―07 The Impact of the COVID-19 Pandemic on the Transplant Pharmacist Workforce Karen Khalil, John Lyons, Jeffrey J. Teuteberg, Erik J. Henricksen
13 [GO] 2022―Aug―05 Risk Factors Associated With Opioid/Benzodiazepine Iatrogenic Withdrawal Syndrome in COVID-19 Acute Respiratory Distress Syndrome Melissa Vu Maffei, Spencer Laehn, Monica Bianchini, Andy Kim
14 [GO] 2022―Jul―21 The COVID-19 Vaccine Conundrum: An Assessment of Vaccine Hesitancy Amongst Patients at a Federally Qualified Health Center Letoia R. Clark, Mark Thomas Sawkin, Brittany Lee Melton, Emma Grace Meyer
15 [GO] 2022―Jul―04 Incorporation of an Efficient Pharmacist Workflow During the Transition From In-Person to Telemedicine Geriatric Clinics in Response to the COVID-19 Pandemic Jeffrey C. Reist, Brent Zahn, Onyeche Oche, Zacariah K. Shannon, Carri Casteel, Richard C. Dobyns, Korey A. Kennelty
16 [GO] 2022―Jun―18 The Race for COVID-19 Vaccines: The Various Types and Their Strengths and Weaknesses Bahaar K. Muhar, Jeffrey Nehira, Ashim Malhotra, Simeon O. Kotchoni
17 [GO] 2022―May―18 Efficacy and Safety of Sitagliptin in the Treatment of COVID-19 Ehab Mudher Mikhael, Siew Chin Ong, Siti Maisharah Sheikh Ghadzi
18 [GO] 2022―Apr―24 Barriers to COVID-19 Vaccines and Strategies to Improve Acceptability and Uptake George T. Nawas, Rana S. Zeidan, Cole A. Edwards, Rania H. El-Desoky
19 [GO] 2022―Apr―13 Community Pharmacy Credentialing for Medical Insurance to Facilitate Sustainability in COVID-19 Testing Elaine Nguyen, Patricia M. Healey, Renee Robinson, Jennifer L. Adams, Shanna K. O’Connor
20 [GO] 2022―Apr―07 Clinical Advanced Pharmacy Practice Experience Rotations During COVID-19: Evaluation of a Transition to Virtual Learning Casey C. May, Sara A. Atyia, Amanda J. Hafford, Keaton S. Smetana
21 [GO] 2022―Mar―31 New Jersey Pharmacists’ Perceptions on Performing COVID-19 Testing in Community Pharmacy Practice Sites Lindsay A. Brust-Sisti, Mark E. Armanious, Kelly Ohlinger, Jainaben Patel, Tanvi Lodhia, Marc G. Sturgill, Lucio R. Volino
22 [GO] 2022―Mar―31 In It for the Long Haul: Post-Acute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Rena Gosser, Sarah Anderson, Amie Blaszczyk, Christi Jen, Snehal Bhatt
23 [GO] 2022―Mar―25 Barriers to Community Pharmacists Referring Patients With Suspected COVID-19 Symptoms Mohamed Bahlol, Zachary Z. Sum, Rebecca Susan Dewey
24 [GO] 2022―Mar―25 Intravenous N-Acetylcysteine in Management of COVID-19: A Case Series Brandon Chen, Karan Raja, Frantz Pierre-Louis, Mitesh Patel, Ruben Patel, Soo Kang, et al. (+3)
25 [GO] 2022―Mar―11 Infectious Diseases Virtual Topic Discussions: Co-preceptorship Adaptations During a Global Pandemic Bryan P. White, Athena L. V. Hobbs
26 [GO] 2022―Jan―10 Analysis of Pharmacist Interventions in Adult COVID-19 Patients Admitted to a Tertiary Care Hospital Osama Al-Quteimat, Mohammad Siddiqui, Lana Hussein, Haytham Al Emleh, Imad EL Dine Shamieh
27 [GO] 2021―Dec―24 Enoxaparin Use in Hospitalized SARS-CoV-2-Positive Patients with Elevated D-Dimer: A Pilot Study Yuliana Zalivansky, Luis Pereira, Aliaksandr Budovich
28 [GO] 2021―Oct―25 Evaluation of Hospitalized Patient Outcomes in COVID-19 Infection for Continued versus Discontinued Use of Preadmission Antiplatelet Regimen Angela Antoniello, Alison Brophy, Yekaterina Opsha
29 [GO] 2021―Oct―22 Cisatracurium Dosing Requirements in COVID-19 Compared to Non-COVID-19 Patients Megan Ingebrigtson, Nicholas Farina, James Miller, Karl Renius, Jakob I. McSparron, Michael Kenes
30 [GO] 2021―Oct―01 COVID-19: A Review of Potential Treatments (Corticosteroids, Remdesivir, Tocilizumab, Bamlanivimab/Etesevimab, and Casirivimab/Imdevimab) and Pharmacological Considerations Salin Nhean, Mario E. Varela, Y-Nha Nguyen, Alejandra Juarez, Tuyen Huynh, Darlington Udeh, Alice L. Tseng
31 [GO] 2021―Jul―30 What We Learnt After Looking Back At the Community Pharmacists’ Experiences Worldwide in COVID-19 Pandemic Seif El Hadidi, Kamal Sabra
32 [GO] 2021―Jul―22 Antibiotic Use and Associated Risk Factors for Antibiotic Prescribing in COVID-19 Hospitalized Patients Alysa J. Martin, Stephanie Shulder, David Dobrzynski, Katelyn Quartuccio, Kelly E. Pillinger
33 [GO] 2021―Jul―20 Evaluation of Rocuronium Continuous Infusion in Critically Ill Patients During the COVID-19 Pandemic and Drug Shortages Mohammed Aldhaeefi, Kevin M. Dube, Mary P. Kovacevic, Paul M. Szumita, Kenneth E. Lupi, Jeremy R. DeGrado
34 [GO] 2021―Jul―17 Development of an Online Telepharmacy Service in the Philippines and Analysis of Its Usage During the COVID-19 Pandemic Aldrin Nico R. Plantado, Harold Joshua dV. de Guzman, Jose Emmanuel C. Mariano, Maria Rosewynn Anne R. Salvan, Christine Aileen C. Benosa, Yolanda R. Robles
35 [GO] 2021―Jul―07 Impact of Tocilizumab on Clinical Outcomes in COVID-19-Associated Cytokine Release Syndrome: A Single-Center Experience Karan Raja, Nicole Daniel, Susan Morrison, Ruben Patel, Jessica Gerges, Komal Nadeem, et al. (+7)
36 [GO] 2021―Jun―15 Hospital Pharmacy Response to Covid-19 Pandemic in Italy: What We Learned From the First Outbreak Wave Vera Damuzzo, Riccardo Bertin, Daniele Mengato, Marco Chiumente, Melania Rivano, Angelo Claudio Palozzo
37 [GO] 2021―Jun―08 Use of Intravenous Vitamin C in Critically Ill Patients With COVID-19 Infection Matthew Li, Tsung Han Ching, Christopher Hipple, Ricardo Lopez, Asad Sahibzada, Habibur Rahman
38 [GO] 2021―Jun―08 Non-Sterile to Sterile Compounding: An Unconventional Response During the COVID-19 Pandemic Caryn D. Belisle, Kevin Anger, Dareen Kanaan, Megan A. Rocchio, Angela Triggs, Pablo Chacon, et al. (+4)
39 [GO] 2021―May―18 Under the Microscope: A Look Into the Role of Critical Care Pharmacists During the COVID-19 Pandemic Payal K. Gurnani, Gary D. Peksa, Nicholas G. Panos, Joshua M. DeMott
40 [GO] 2021―May―09 The Impact of Anticoagulation on COVID-19 (SARS CoV-2) Patient Outcomes: A Systematic Review Dovena Lazaridis, Simon Leung, Lisa Kohler, Carla Hawkins Smith, Margaretta L. Kearson, Nathaniel Eraikhuemen
41 [GO] 2021―Apr―28 The Rise and Fall of Hydroxychloroquine and Chloroquine in COVID-19 Rana Aljadeed
42 [GO] 2021―Apr―22 Treatment of Severe Hypertriglyceridemia With Insulin Infusions in Severe COVID-19: A Case Series Caitlin M. Thomas, Martie Vicent, Shawn Moore, Fahd Ali, Leslie Wooten, Patricia R. Louzon
43 [GO] 2021―Apr―15 Probable Interaction Between Warfarin and the Combination of Remdesivir With Dexamethasone for Coronavirus Disease 2019 (COVID-19) Treatment: A 2 Case Report Ronald Patrick Landayan, Sampson Saint-Felix, Ashley Williams
44 [GO] 2021―Apr―12 Review of COVID-19 mRNA Vaccines: BNT162b2 and mRNA-1273 Shyh Poh Teo
45 [GO] 2021―Apr―02 Development of a Remote Public Health Advanced Pharmacy Practice Experience in Response to COVID-19 Tyler Marie Kiles, Tracy Hagemann, Brianna Felts, Catherine Crill
46 [GO] 2021―Mar―30 Optimizing Emergency Medicine Pharmacists’ Practice During the COVID-19 Pandemic Erin D. Wieruszewski, Alicia E. Mattson, Francis C. Manuel, Caitlin S. Brown
47 [GO] 2021―Mar―24 Interleukin-6 Antagonists: Lessons From Cytokine Release Syndrome to the Therapeutic Application in Severe COVID-19 Infection Jennis Meanwatthana, Teerapat Majam
48 [GO] 2021―Mar―19 Tocilizumab for the Critically Ill With Severe COVID-19: A Community Hospital Case Series Matt G. McKenzie, Yeunju (Michelle) Lee, Julin Mathew, Megan Anderson, Alison T. Vo, Samuel Akinyele, Malarvizhi Narayanan
49 [GO] 2021―Mar―16 A Review of the Evidence for Corticosteroids in COVID-19 Meagan Johns, Stephy George, Margarita Taburyanskaya, Yi Kee Poon
50 [GO] 2021―Mar―15 Warfarin Dose Requirements in Adults Hospitalized With COVID-19 Infection: A Retrospective Case Series Madison N. Irwin, Sarah Adie, Katherine Sandison, Sarah A. Alsomairy, Adamo Brancaccio
51 [GO] 2021―Feb―24 Remdesivir for the Treatment of COVID-19: A Need for Combined In Vivo and In Vitro Studies to Evaluate the Efficacy Muhammad Naveed, Shahab Uddin, Muhammad Khalid Khan, Zakir Khan
52 [GO] 2021―Jan―18 Clinical Consideration of Glucocorticoids in COVID-19 Ahmed Samy Elnoby
53 [GO] 2020―Dec―15 Community Pharmacists Roles During the COVID-19 Pandemic Karl Hess, Albert Bach, Kimberly Won, Sheila M. Seed
54 [GO] 2020―Dec―11 A Response to the Recommendations for Using Dexamethasone for the Treatment of COVID-19: The Dark Side of Dexamethasone Mohamed A. Salem
55 [GO] 2020―Dec―10 An Unusual Case of COVID-19 Presenting as Acute Psychosis Cameron G. Lanier, Stacey A. Lewis, Paras D. Patel, Ahmed Mohamed Ahmed, Paul O. Lewis
56 [GO] 2020―Dec―03 Strategies for Managing Pharmacy Experiential Education During COVID-19 Cynthia Moreau, Stacey Maravent, Genevieve M. Hale, Tina Joseph
57 [GO] 2020―Nov―03 Specialized Pharmacist Roles and Perspectives in the Collaborative Management of COVID-19 Erik Skoglund, Joelle Ayoub, Huan Mark Nguyen
58 [GO] 2020―Oct―14 Continuous Infusion Low-Dose Unfractionated Heparin for the Management of Hypercoagulability Associated With COVID-19 Matthew Li, Steven Gitarts, Akwe Nyabera, Ravali Kondaveeti, Yousef Hammudeh, Carlos Gonzalez, et al. (+6)
59 [GO] 2020―Oct―05 Utilizing Pharmacists to Optimize Medication Management Strategies During the COVID-19 Pandemic L. Hayley Burgess, Mandelin K. Cooper, Elizabeth H. Wiggins, Karla M. Miller, Edward Murray, Scott Harris, Joan S. Kramer
60 [GO] 2020―Aug―06 Curbside Coumadin Clinics Offer Testing During COVID-19 Crisis Jared Ostroff, Shawn Roggie, Brandon Opitz
61 [GO] 2020―Jul―31 Hydroxychloroquine Alternatives for Chronic Disease: Response to a Growing Shortage Amid the Global COVID-19 Pandemic Sameeha S. Husayn, Jeremy D. Brown, Colby L. Presley, Kelsey Boghean, Jacquelyn D. Waller

61 Results       Page 1


Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.014 sec